Tin tức & Cập nhật
Lọc theo Chuyên ngành:

START-FIT: TACE + RT + avelumab promising as conversion therapy for locally advanced unresectable HCC
18 Jan 2023
bởiNatalia Reoutova
START-FIT, a prospective, single-arm, phase II trial, has found sequential transarterial chemoembolization (TACE) and stereotactic body radiotherapy (SBRT) followed by anti–PD-L1 treatment with avelumab to be a promising strategy for making patients with locally advanced unresectable hepatocellular carcinoma (HCC) amenable to curative treatment.
START-FIT: TACE + RT + avelumab promising as conversion therapy for locally advanced unresectable HCC
18 Jan 2023
Bepirovirsen shows promise in controlling chronic HBV infection
19 Dec 2022
bởiRoshini Claire Anthony
Weekly bepirovirsen treatment may help reduce HBsAg* and hepatitis B virus (HBV) DNA levels in patients with chronic HBV infection, the phase IIb B-Clear study showed.